Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

Leona Dold; Golo Ahlenstiel; Eva Althausen; Carolin Luda; Carolynne Schwarze-Zander; Christoph Boesecke; Jan-Christian Wasmuth; Jürgen Kurt Rockstroh; Ulrich Spengler

doi:10.1371/journal.pone.0134158

Loading metrics

Open Access

Peer-reviewed

Research Article

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

Leona Dold ,

* E-mail: Leona.Dold@ukb.uni-bonn.de

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Golo Ahlenstiel,

Affiliation Westmead Clinical School, University of Sydney, Sydney, Australia
⨯
Eva Althausen,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Carolin Luda,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Carolynne Schwarze-Zander,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Christoph Boesecke,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Jan-Christian Wasmuth,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Jürgen Kurt Rockstroh,

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯
Ulrich Spengler

Affiliations Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany
⨯

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

Leona Dold,
Golo Ahlenstiel,
Eva Althausen,
Carolin Luda,
Carolynne Schwarze-Zander,
Christoph Boesecke,
Jan-Christian Wasmuth,
Jürgen Kurt Rockstroh,
Ulrich Spengler

x

Published: August 4, 2015
https://doi.org/10.1371/journal.pone.0134158

Viewed

Cited

Saved

Discussed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Co-infections
Is the Subject Area "Co-infections" applicable to this article?

Thanks for your feedback.
Highly-active antiretroviral therapy
Is the Subject Area "Highly-active antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Sepsis
Is the Subject Area "Sepsis" applicable to this article?

Thanks for your feedback.